Thrivent Financial for Lutherans reduced its position in CVS Health Co. (NYSE:CVS – Free Report) by 19.3% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 123,551 shares of the pharmacy operator’s stock after selling 29,597 shares during the period. Thrivent Financial for Lutherans’ holdings in CVS Health were worth $7,297,000 at the end of the most recent quarter.
Several other large investors have also recently modified their holdings of the company. Ables Iannone Moore & Associates Inc. purchased a new position in CVS Health during the 4th quarter worth $32,000. Creekmur Asset Management LLC acquired a new stake in CVS Health in the 4th quarter worth approximately $34,000. Steph & Co. grew its position in CVS Health by 192.0% during the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after purchasing an additional 288 shares during the last quarter. Kapitalo Investimentos Ltda acquired a new position in CVS Health during the 4th quarter valued at approximately $36,000. Finally, Scarborough Advisors LLC purchased a new position in shares of CVS Health in the fourth quarter worth $37,000. Institutional investors own 80.66% of the company’s stock.
CVS Health Trading Up 0.6 %
NYSE CVS opened at $59.02 on Friday. CVS Health Co. has a 52 week low of $52.77 and a 52 week high of $83.25. The firm has a 50 day moving average of $58.18 and a two-hundred day moving average of $62.17. The stock has a market capitalization of $74.09 billion, a PE ratio of 10.37, a price-to-earnings-growth ratio of 0.81 and a beta of 0.53. The company has a quick ratio of 0.66, a current ratio of 0.86 and a debt-to-equity ratio of 0.83.
CVS Health Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Stockholders of record on Monday, October 21st will be given a dividend of $0.665 per share. The ex-dividend date is Monday, October 21st. This represents a $2.66 annualized dividend and a dividend yield of 4.51%. CVS Health’s dividend payout ratio is presently 46.75%.
Analyst Ratings Changes
Several research firms have weighed in on CVS. Cantor Fitzgerald reiterated a “neutral” rating and set a $62.00 price target on shares of CVS Health in a research note on Monday, September 16th. Wells Fargo & Company increased their price target on CVS Health from $60.00 to $61.00 and gave the stock an “equal weight” rating in a research report on Monday, August 12th. JPMorgan Chase & Co. decreased their price objective on CVS Health from $101.00 to $86.00 and set an “overweight” rating for the company in a report on Thursday, May 30th. Baird R W raised CVS Health to a “hold” rating in a report on Thursday, May 30th. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $68.00 price target on shares of CVS Health in a report on Wednesday, September 4th. Eleven research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $72.10.
Get Our Latest Report on CVS Health
CVS Health Company Profile
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
See Also
- Five stocks we like better than CVS Health
- Manufacturing Stocks Investing
- Rocket Lab Stock Soars: Should Investors Chase the Rally?
- Breakout Stocks: What They Are and How to Identify Them
- KB Home Slips After Earnings: What’s Next for Homebuilders?
- Where Do I Find 52-Week Highs and Lows?
- Micron Stock Soars as AI Demand Fuels Big Q4 Earnings Beat
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.